iiinova — where your digital self keeps evolving

Anna Roberts

@drannaroberts.bsky.social

Postdoc @ImperialCollege | Neuroendocrinology, metabolism, reproductive & women’s health 🧠👩🏼‍🔬 | Outdoor enthusiast 🌿 |

Anna Roberts @drannaroberts.bsky.social · 26/11/2025

Thank you to the @ox.ac.uk Cortex Club for the chance to discuss the latest @novonordisk.bsky.social EVOKE & EVOKE+ trial updates, and the role we believe GIPR plays in maintaining vascular health 🧠✨ Great discussion and insightful questions 🙏 Manuscript out soon — stay tuned 📄📢

010

Reposted by Anna Roberts

CCMN @ccmnlondon.bsky.social · 25/11/2025

📣 New review out from @trapp-lab.bsky.social! Read to learn about the physiology and anti-obesity potential of preproglucagon neurons 🧠 Link here: academic.oup.com/endo/article...

academic.oup.com

Brain-Derived GLP-1—Understanding the Physiological Function and Anti-obesity Potential of Preproglucagon Neurons

Abstract. Glucagon-like peptide-1 (GLP-1) is produced within the central nervous system (CNS) by preproglucagon (PPG) neurons. This brain-derived GLP-1, ra

074

Anna Roberts @drannaroberts.bsky.social · 26/09/2025

…and just like that, 2.5 great years come to an end. Huge thanks to everyone in @ccmnlondon.bsky.social for an amazing first postdoc experience & @adriaenssenslab.bsky.social and @nataliefigueredob.bsky.social for making such a great team! Excited for what’s next @imperialmdr.bsky.social 🚀

250

Anna Roberts @drannaroberts.bsky.social · 14/09/2025

Thanks to @theiups.bsky.social 2025 meeting for a great Vascular Health and Function session where I was pleased to share exciting new data!

021

Anna Roberts @drannaroberts.bsky.social · 19/08/2025

Pleased to share a new paper that I'm proud to have contributed to 🌟 Grateful for the chance to work with such a talented team 🙌

041

Anna Roberts @drannaroberts.bsky.social · 14/08/2025

Really enjoyed working on this - big thanks to everyone involved!

041

Reposted by Anna Roberts

SSIBsociety @ssibsociety.bsky.social · 01/08/2025

4th day highlights from #SSIB 2025!

062

Anna Roberts @drannaroberts.bsky.social · 24/06/2025

A big congratulations to @nataliefigueredob.bsky.social 🥳

020

Anna Roberts @drannaroberts.bsky.social · 20/05/2025

Excited to share a new preprint from work I did during my PhD! 🎉 Here we uncover a direct gut-pancreas neuronal circuit that drives the glucoregulatory response to lipids 🫒 Huge thanks to @imperialcollegeldn.bsky.social and all involved. Read it here 📄: www.biorxiv.org/content/10.1...

biorxiv.org

151

Reposted by Anna Roberts

Alice Adriaenssens @adriaenssenslab.bsky.social · 29/04/2025

It's a big week for GIPR pharmacology! Two great studies out in @natmetabolism.nature.com from Gutgesell et al (www.nature.com/articles/s42...) and Liu et al (www.nature.com/articles/s42...) revealing divergent neural mechanisms engaged by GIPR agonism vs antagonism. Commentary here: rdcu.be/ejPSA

nature.com

GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice - Nature Metabolism

This study, together with a companion manuscript, show that, in mice, weight loss as a result of GIP receptor antagonism requires, and potentiates, functional GLP-1 receptor signalling in the brain, e...

154

Reposted by Anna Roberts

CCMN @ccmnlondon.bsky.social · 07/03/2025

📣Join the Trapp lab as a Postdoctoral Research Fellow! The Trapp lab is seeking for a highly motivated Research Fellow to explore the role of GLP-1 action within the brain. If you are interested we encourage you to apply! 📍 Location: UCL, London 📆 Application deadline: March 19th

153

Reposted by Anna Roberts

Dan Brierley @drdanbrierley.bsky.social · 21/01/2025

Really proud to start the year by sharing our new review in @endosocjournals.bsky.social on the roles of GLP-1 in eating and obesity treatment, led by superstar postdoc @laurenjonesucl.bsky.social! academic.oup.com/endo/article... 🧪🧠📈 #neuroscience #neuroskyence #GLP-1 #obesity #wegovy #ozempic

academic.oup.com

GLP-1 and the Neurobiology of Eating Control: Recent Advances

Abstract. Obesity is now considered a chronic relapsing progressive disease, associated with increased all-cause mortality that scales with body weight, af

59324

Reposted by Anna Roberts

CCMN @ccmnlondon.bsky.social · 02/12/2024

📣 We are excited to launch this year’s CCMN Lecture Series with Dr. @zknight.bsky.social! Join us to learn about his latest work on: In vivo imaging of brainstem neurons in response to nutrient intake. 🗓️ Wednesday, Dec 4, 2024 🕐 13:00 📍 H O Schild Lecture Theatre, Medical Sciences Building

034